Consumers now face more options than ever in shopping, media, finance, travel, health and information. Yet many of those options are shaped by algorithms, subscription systems, default settings and automated tools. Recent surveys and regulatory actions show a growing concern: ...

GLP-1 medicines have moved from diabetes care into the center of obesity treatment. They can produce major weight loss and may lower risks tied to heart disease, sleep apnea and other conditions. They also bring side effects, high costs, supply pressures and concerns about una...